50 Results for "

anyitumor

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "anyitumor" in MCE Product Catalog:

Cat. No.: HY-116447
CAS No.: 1611446-66-2
Purity:  ≥99.0%
Research Areas:  

Cancer

Antitumor agent-159 (Compound 13b) targets the mitochondria and downregulates cardiolipin levels. Antitumor agent-159 inhibits the proliferation of cancer cell MDA-MB-231, arrests the cell cycle at sub-G1 phase, and induces apoptosis in MDA-MB-231. Antitumor agent-159 exhibits antitumor efficacy in MDA-MB-231 xenograft mouse models .
loading...
    loading...
Cat. No.: HY-144394
CAS No.: 2581082-74-6
Target:  

Apoptosis c-Met/HGFR

Research Areas:  

Cancer

Antitumor agent-45 (Compound 21) could induce and stimulate A549 cells apoptosis in G0/G1 and G2/M phase. Antitumor agent-45 (Compound 21) inhibits c-Met expression to regulate the growth of tumor cells .
loading...
    loading...
Cat. No.: HY-107470
CAS No.: 1256037-58-7
Target:  

Drug Derivative

Research Areas:  

Inflammation/Immunology Cancer

Antitumor agent-21 is an aryl-quinolin derivative, with potential anticancer, anti-inflammatory, anti-proliferative, anti-hormonal effects and inhibition of vasculogenic mimicry .
loading...
    loading...
Cat. No.: HY-115948
CAS No.: 2917547-18-1
Target:  

Others

Research Areas:  

Cancer

Antitumor agent-46 (Compound 2h) is an anti-tumor agent. Antitumor agent-46 demonstrates markedly higher antiproliferative activity on MCF-7 cells with an IC50 value of 2.08 µM .
loading...
    loading...
Cat. No.: HY-115949
CAS No.: 2917547-24-9
Target:  

HSP

Research Areas:  

Cancer

Antitumor agent-47 (Compound 3e) is a silibinin derivative with an antitumor activity. Antitumor agent-47 shows cytotoxic activity against NCI-H1299 and HT29 cells with IC50 values of 8.07 µM and 6.27 µM, respectively .
loading...
    loading...
Cat. No.: HY-115950
CAS No.: 2917547-29-4
Target:  

Drug Derivative

Research Areas:  

Cancer

Antitumor agent-48 (Compound 4a) is a 2,3-dehydrosilybin derivative with an antitumor activity. Antitumor agent-48 shows cytotoxic activity against MCF-7, NCI-H1299, HepG2 and HT29 cells with IC50 values of 8.06 µM, 13.1 µM, 16.51 µM and 12.44 µM, respectively .
loading...
    loading...
Cat. No.: HY-115995
CAS No.: 2891985-53-6
Target:  

Drug Derivative

Research Areas:  

Cancer

Antitumor agent-50 (compound 1a), a thiazolidinone, is a potent antitumor agent. Antitumor agent-50 has the potential for osteosarcoma (OS) research .
loading...
    loading...
Cat. No.: HY-115996
CAS No.: 3035774-65-0
Target:  

Apoptosis

Research Areas:  

Cancer

Antitumor agent-51 possesses potent and selective inhibitory for osteosarcoma cell growth and migration with IC50 of 21.9 nM in MNNG/HOS cells. Antitumor agent-51 has a considerable bioavailability and a low toxicity .
loading...
    loading...
Cat. No.: HY-117708
CAS No.: 137346-42-0
Target:  

Drug Intermediate

Research Areas:  

Cancer

Antitumor agent-144 (16) is an antitumor agent, with IC50 values of 2.6 μM and 8.4 μM in L1210 and KB cells, respectively .
loading...
    loading...
Cat. No.: HY-128776
CAS No.: 2379727-90-7
Target:  

TNF Receptor

Research Areas:  

Cancer

Antitumor agent-19 is an antitumor agent that targets tumor-associated macrophages (TAMs) and can be used as a potent TAMs modulator. Antitumor agent-19 can increase TNF-alpha levels in tumor cells with EC50 values???of 17.18 μM and 18.87 μM in RAW 264.7 cells and BMDM cells, respectively .
loading...
    loading...
Cat. No.: HY-128934
CAS No.: 1351163-57-9
Target:  

Others

Research Areas:  

Inflammation/Immunology Cancer

Antitumor agent-2 is sourced from patent CN102250203, compound 6a-r, has antitumor action and anti-inflammatory action .
loading...
    loading...
Cat. No.: HY-136342
CAS No.: 2355185-12-3
Target:  

Others

Research Areas:  

Cancer

Antitumor agent-23 is a potent anti-cancer agent with GI50s of 38, 48, 5, 27, 80, and 28 nM for lymphoma cell line GRANTA-519, KARPAS-422, KARPAS-299, RAMOS, DAUDI, and RAJI, respectively. Antitumoral activity .
loading...
    loading...
Cat. No.: HY-139735
CAS No.: 2847856-44-2
Target:  

Drug Intermediate

Research Areas:  

Cancer

Antitumor agent-29 is a novel hepatocyte-targeting antitumor proagent, which exhibits good antitumor activity and low toxic side effects.
loading...
    loading...
Cat. No.: HY-139975
CAS No.: 2703000-00-2
Target:  

Fluorescent Dye

Research Areas:  

Cancer

Antitumor agent-31 is a nanosized chelates of anchoring bisazo dye. Antitumor agent-31 can be used for an antioxidant and antitumor agent .
loading...
    loading...
Cat. No.: HY-141478
CAS No.: 2097499-67-5
Target:  

ATM/ATR

Research Areas:  

Cancer

Antitumor agent-28 selectively inhibits ataxia telangiectasia mutated (ATM) kinase. Antitumor agent-28 prevents ATM mediated disease and has potent anti-cancer activity .
loading...
    loading...
Cat. No.: HY-142086
CAS No.: 2096500-09-1
Target:  

Drug Derivative

Research Areas:  

Cancer

Antitumor agent-40 is an antitumor agent. Antitumor agent-40 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-144125
CAS No.: 3035564-55-4
Target:  

Apoptosis

Research Areas:  

Cancer

Antitumor agent-41 (compound N-12), a potent antitumor agent, enhibits excellent antimigration and anti-invasion activity. Antitumor agent-41 (compound N-12) induces tumor inhibition via tumor necrosis and inflammatory response .
loading...
    loading...
Cat. No.: HY-144331
CAS No.: 2763621-91-4
Research Areas:  

Cancer

Antitumor agent-42 (Compound 15h) is a bifunctional agent exhibiting both tubulin polymerized inhibition and NO-releasing activities, resulting in potent anti-angiogenesis, colony formation inhibition, cell cycle arrest and apoptosis induction effects .
loading...
    loading...
Cat. No.: HY-144340
CAS No.: 2766035-37-2
Research Areas:  

Cancer

Antitumor agent-43 (Compound 4B) is a potent antitumor agent, with an IC50of 0.5 µM for (T-24 cell). Antitumor agent-43 (Compound 4B) induces cell cycle arrest at G2/M phase .
loading...
    loading...
Cat. No.: HY-144361
CAS No.: 1811548-74-9
Target:  

Apoptosis

Research Areas:  

Cancer

Antitumor agent-44 (Compound 5n) disrupts the mitochondrial homeostasis, induces cell cycle arrest and apoptosis in human adenocarcinoma cells. Antitumor agent-44 (Compound 5n) possesses good anti-tumor activity in a lung-cancer-cell xenograft mice model .
loading...
    loading...